BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24373635)

  • 1. Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa.
    Tindall EA; Bornman MS; van Zyl S; Segone AM; Monare LR; Venter PA; Hayes VM
    BMC Urol; 2013 Dec; 13():74. PubMed ID: 24373635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation of prostate cancer in black South Africans.
    Tindall EA; Monare LR; Petersen DC; van Zyl S; Hardie RA; Segone AM; Venter PA; Bornman MS; Hayes VM
    Prostate; 2014 Jun; 74(8):880-91. PubMed ID: 24723425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking African ancestral substructure to prostate cancer health disparities.
    Gheybi K; Mmekwa N; Lebelo MT; Patrick SM; Campbell R; Nenzhelele M; Soh PXY; Obida M; Loda M; Shirindi J; Butler EN; Mutambirwa SBA; Bornman MSR; Hayes VM
    Sci Rep; 2023 Nov; 13(1):20909. PubMed ID: 38017150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African KhoeSan ancestry linked to high-risk prostate cancer.
    Petersen DC; Jaratlerdsiri W; van Wyk A; Chan EKF; Fernandez P; Lyons RJ; Mutambirw SBA; van der Merwe A; Venter PA; Bates W; Bornman MSR; Hayes VM
    BMC Med Genomics; 2019 Jun; 12(1):82. PubMed ID: 31164124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining laboratory data to describe prostate specific antigen testing and prostate cancer in Johannesburg, South Africa.
    Maphayi MR; Cassim N; Bello B; George JA
    Pan Afr Med J; 2020; 35():61. PubMed ID: 32537065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating racial differences in clinical and pathological features of prostate cancer in South African men.
    Dewar M; Kaestner L; Zikhali Q; Jehle K; Sinha S; Lazarus J
    S Afr J Surg; 2018 Jun; 56(2):54-58. PubMed ID: 30010267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems with prostate specific antigen screening for prostate cancer in the primary healthcare setting in South Africa.
    Heyns CF; Mathee S; Isaacs A; Kharwa A; De Beer PM; Pretorius MA
    BJU Int; 2003 Jun; 91(9):785-8. PubMed ID: 12780832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
    Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
    Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of mitochondrial genomic variation and associated clinical presentation of prostate cancer in South African men.
    McCrow JP; Petersen DC; Louw M; Chan EK; Harmeyer K; Vecchiarelli S; Lyons RJ; Bornman MS; Hayes VM
    Prostate; 2016 Mar; 76(4):349-58. PubMed ID: 26660354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.
    Giri VN; Egleston B; Ruth K; Uzzo RG; Chen DY; Buyyounouski M; Raysor S; Hooker S; Torres JB; Ramike T; Mastalski K; Kim TY; Kittles R
    Cancer Prev Res (Phila); 2009 Mar; 2(3):244-50. PubMed ID: 19240249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential selection bias in a community-based study of PSA levels in African-American men.
    Heeringa SG; Alcser KH; Doerr K; Strawderman M; Cooney K; Medbery B; Schottenfeld D
    J Clin Epidemiol; 2001 Feb; 54(2):142-8. PubMed ID: 11166529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naïve, High-Risk Prostate Cancer.
    Jaratlerdsiri W; Chan EKF; Gong T; Petersen DC; Kalsbeek AMF; Venter PA; Stricker PD; Bornman MSR; Hayes VM
    Cancer Res; 2018 Dec; 78(24):6736-6746. PubMed ID: 30217929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans.
    Whittemore AS; Cirillo PM; Feldman D; Cohn BA
    J Urol; 2005 Sep; 174(3):872-6; discussion 876. PubMed ID: 16093978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Custom Genotyping Array Reveals Population-Level Heterogeneity for the Genetic Risks of Prostate Cancer and Other Cancers in Africa.
    Harlemon M; Ajayi O; Kachambwa P; Kim MS; Simonti CN; Quiver MH; Petersen DC; Mittal A; Fernandez PW; Hsing AW; Baichoo S; Agalliu I; Jalloh M; Gueye SM; Snyper NYF; Adusei B; Mensah JE; Abrahams AOD; Adebiyi AO; Orunmuyi AT; Aisuodionoe-Shadrach OI; Nwegbu MM; Joffe M; Chen WC; Irusen H; Neugut AI; Quintana Y; Seutloali M; Fadipe MB; Warren C; Woehrmann MH; Zhang P; Ongaco CM; Mawhinney M; McBride J; Andrews CV; Adams M; Pugh E; Rebbeck TR; Petersen LN; Lachance J
    Cancer Res; 2020 Jul; 80(13):2956-2966. PubMed ID: 32393663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research.
    Littlejohns TJ; Travis RC; Key TJ; Allen NE
    Cancer Epidemiol; 2016 Dec; 45():40-46. PubMed ID: 27693812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection.
    Hughes L; Zhu F; Ross E; Gross L; Uzzo RG; Chen DY; Viterbo R; Rebbeck TR; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):53-60. PubMed ID: 22144497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8q24 risk alleles and prostate cancer in African-Barbadian men.
    Cropp CD; Robbins CM; Sheng X; Hennis AJ; Carpten JD; Waterman L; Worrell R; Schwantes-An TH; Trent JM; Haiman CA; Leske MC; Wu SY; Bailey-Wilson JE; Nemesure B
    Prostate; 2014 Dec; 74(16):1579-88. PubMed ID: 25252079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalizability of established prostate cancer risk variants in men of African ancestry.
    Han Y; Signorello LB; Strom SS; Kittles RA; Rybicki BA; Stanford JL; Goodman PJ; Berndt SI; Carpten J; Casey G; Chu L; Conti DV; Rand KA; Diver WR; Hennis AJ; John EM; Kibel AS; Klein EA; Kolb S; Le Marchand L; Leske MC; Murphy AB; Neslund-Dudas C; Park JY; Pettaway C; Rebbeck TR; Gapstur SM; Zheng SL; Wu SY; Witte JS; Xu J; Isaacs W; Ingles SA; Hsing A; ; ; Easton DF; Eeles RA; Schumacher FR; Chanock S; Nemesure B; Blot WJ; Stram DO; Henderson BE; Haiman CA
    Int J Cancer; 2015 Mar; 136(5):1210-7. PubMed ID: 25044450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
    Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
    JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer.
    Chang BL; Hughes L; Chen DY; Gross L; Ruth K; Giri VN
    BJU Int; 2014 May; 113(5b):E150-6. PubMed ID: 23937305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.